Open Journal Systems

Japanese Initiative for Education in Pharmaceutical Medicine and Clinical Research Training

Akiko Kishi, Ichiro Uchida, Daisuke Koide, Kyoko Imamura

Article ID: 166
Vol 4, Issue 1, 2019, Article identifier:1-9

VIEWS - 818 (Abstract) 605 (PDF)


Development of new medicines has become increasingly difficult with less possibility of success in seeds-finding and ever rising operational costs. Failure to comply with ethical standards for human research protection also erodes social trust in clinical development. In order to develop competence of professionals in medicines development such as clinical investigators and drug development scientists, a variety of educational courses and training programs have been developed and executed worldwide. As Japan is no exception and shares the same concerns, significant governmental and non-governmental efforts have been made to invest in the development of academic educational courses and adherence to international standards. This article introduces examples of the adoption of technologies to realize a user-friendly and sustainable learning management as well as an adaptation of syllabuses and core curricula to meet international standards in the era of global medicines development.


PharmaTrain; CLIC; CREDITS; JAPhMed; SMD; pharmaceutical medicine; learning management system; continuous education

Full Text:


Included Database


PharmaTrain manual curriculum standards and best practices ver. 2.0, 2014, n.d., viewed October 15, 2016.

DiMasi J A, Grabowski H G, Hansen R W, 2016, Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47: 20–33.

Nosengo N, 2016, Can you teach old drugs new tricks? Nature, 534(7607): 314–316.

Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK., n.d., viewed October 15, 2016.

Dubois D J, Jurczynska A, Kerpel-Fronius S, et al. 2016, Fostering competence in medicines development: The IFAPP perspective. Frontiers in Pharmacology, 7: 377.

PharmaTrain mastering medicine development, n.d., viewed October 15, 2016.

Ono S, Tsutani K, Shibata T, et al. 2003, Clinical trials in Japan after implementation of the International Conference on Harmonization—Good Clinical Practice (ICHGCP) guidelines, Pharmaceutical Development and Regulation, 1(2): 81–89.

Pacific Bridge Medical, 2013, Japan 5-years clinical research and trial activation plan 2012, n.d., viewed September 28, 2016.

University Hospital Medical Information Network Center, n.d., viewed September 28, 2016.

Clinical Data Interchange Standard Consortium, n.d., viewed September 28 2016.

Pharmaceuticals and Medical Devices Agency, n.d, viewed September 28, 2016.

Moodle, n.d., viewed September 28, 2016.

Ministry of Health, Labour and Welfare, The ethical guidelines for medical and health research involving human subjects: Provisional translation (as of March 2015).


Swissethics, List of Swissethics recognized Research Ethics and GCP course providers.

Koren M J, Koski G, Reed D P, et al. 2011, Statement of clinical investigator competence, APCR consensus statement. The Monitor, 25(4): 79–82.

European Science Foundation, 2003, A European syllabus for training clinical investigators, viewed October 24, 2016.

Boeynaems J M, Canivet C, Chan A, et al. 2013, A European approach to clinical investigator training. Frontiers in Pharmacology, 4: 112.

eCLIC: an online course for clinical investigators and their teams, n.d., viewed October 20, 2016.

CITI-Japan Program, Responsible conduct of research (RCR), n.d., viewed October 20, 2016.

PharmaTrain specialist in medicines development (SMD) procedural document, 2014, n.d., viewed October 15, 2016.>

Silva H, Stonier P, Buhler F, et al. 2013, Core competencies for pharmaceutical physicians and drug development scientists. Frontiers in Pharmacology, 4: 105.

(818 Abstract Views, 605 PDF Downloads)


  • There are currently no refbacks.

Copyright (c) 2017 KYOKO IMAMURA

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.